Идёт
Фаза II
Армения
TX000045- Dose A; TX000045- Dose B; Placebo · Tectonic Therapeutic
A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of TX000045 After 24 Weeks of Treatment in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF)